Toyota Motor Corporation designs, manufactures, assembles, and sells passenger vehicles, minivans and commercial vehicles, and related parts and accessories in Japan, North America, Europe, Asia, Central and South Americ…
FAIL · Does not pass the screen
196.79 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago
Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price196.79 USD at the 23 Oct 2026 close
Our ratingAvoid, current read accumulation
Ethical screenDoes not pass
OptionsOpen interest leans heavily to calls (put/call 0.57)
Last reviewed23 Oct 2026 (5 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 196.79 against the desk's fair-value range, base estimate 183.42, over the last year.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.57, read 2026-10-24
Ethical does not pass the values gate
Price196.79 USD
Fair value183.42
Ethical score70.0/100
RatingAVOID
Our investment reviews on this name
2026-10-25Read Accumulation191.94+2.5% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown190.34+3.4% to today Accumulation gives way to Markdown first Markdown read since July
2026-09-06Read Accumulation192.24+2.4% to today ✓Markup gives way to Accumulation after an 8% rise in 5 weeks
2026-08-03Read Markup177.42+10.9% to today ✓Distribution gives way to Markup with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Toyota Motor holds its Accumulation at $196.79. Consolidating, no directional conviction, held for 68 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 68 days
Price at the screen
$196.79
Valuation
8.44 trailing · 12.16 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.38
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio 41.4%
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
41.44%
Below 33%
Interest-bearing debt is 41.4% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
9.60%
Below 33%
Cash held in interest-bearing accounts and securities is 9.6% of assets, under the one-third limit.
Pass
Receivables
23.69%
Below 49%
Money owed to the company is 23.7% of assets, under the 49% limit.
Pass
Revenue purity
0.51%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Toyota Motor's business is in a permissible area, but its interest-bearing debt is about 41% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TM's ethical verdict changes
Today TM does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · AFSC Investigate, Who Profits Corporate Database
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate / Who Profits Corporate Database — category: Population Control | Specialized Equipment and Services. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades above our $183.42 fair value estimate, 10.40% revenue growth.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 4.4% above the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +19% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Toyota's Value Trap in a Cyclical Downturn
When you think of wheels and engines, Toyota's name rolls off the tongue. It's a household name designing, manufacturing and selling vehicles across continents, from minivans to commercial juggernauts. But, in the cyclical world of automobiles, a low P/E can be a mirage, not a bargain. Toyota is showing one now with a forward P/E of 12.2x, which might look appealing at first glance, but its cyclical nature could mean peak earnings are being priced in, not a sustainable value.
The numbers tell a tale of a business that's doing well, with a revenue growth of 10% and a decent profit margin of 9%. However, the ethical screen is a red flag here. Toyota fails, primarily due to its debt ratio of 41.4%, a critical factor in our assessment. Combine this with the cyclical nature of the industry, and the value trap becomes a significant risk. The market consensus, represented by four analysts with no consensus rating, sees a median target of $234. Yet, our fair value sits at $183.42, reflecting a margin of safety of -5%, indicating that the current price is above our estimated intrinsic value.
Risk is high here, and it's not just about the numbers. The debt ratio fails our ethical screen, and the cyclical nature of the auto industry means that what looks like a low P/E could be a warning sign rather than a buying opportunity. It's a classic case of where the ethical and financial risks align, pushing us to avoid. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TM trades on NYSE (ADR) (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257.
2026-10-18Markdown$191.94+0.8%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257.
2026-10-02Markdown · changed$190.34-1.0%Entry 13
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257.
2026-08-06Markup$185.89+4.8%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-05Markup$177.42+0.0%Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-04Markup$177.42+0.0%Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-03Markup · changed$177.42+0.0%Entry 8
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-02Distribution$177.42+0.0%Entry 7
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-01Distribution$177.42+0.0%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (4 analysts) rates it strong buy, with a mean price target of $257. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
